Incannex Ltd announces final results from Phase 1 Clinical Trial assessing safety and pharmacokinetics of IHL-675A
Final results are in for a Phase 1 clinical trial to assess pharmacokinetics and the safety of Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL)’s...